Savvy Advisors Inc. Acquires 102 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Savvy Advisors Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% during the first quarter, HoldingsChannel reports. The fund owned 546 shares of the medical equipment provider’s stock after purchasing an additional 102 shares during the quarter. Savvy Advisors Inc.’s holdings in Intuitive Surgical were worth $270,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Global Financial Private Client LLC grew its holdings in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares during the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $26,000. Finally, LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 0.1%

Shares of NASDAQ ISRG opened at $470.08 on Monday. The firm has a market cap of $168.51 billion, a PE ratio of 65.56, a P/E/G ratio of 4.93 and a beta of 1.59. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company’s fifty day simple moving average is $516.52 and its 200 day simple moving average is $528.23.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company posted $1.78 earnings per share. The business’s revenue was up 21.4% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,881 shares of company stock worth $7,920,634. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. Citigroup reissued a “buy” rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. UBS Group upped their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Truist Financial upped their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Finally, Royal Bank Of Canada upped their price objective on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.